Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Debt/Equity

    Back to All Ratios
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Total Debt/Equity(x) 0.250.130.460.400.67

What is the latest Total Debt/Equity ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Debt/Equity ratio of GLENMARK PHARMACEUTICALS is 0.25 based on Mar2025 Consolidated results.
Year Total Debt/Equity
Mar20250.25
Mar20240.13
Mar20230.46
Mar20220.40
Mar20210.67

How is Total Debt/Equity of GLENMARK PHARMACEUTICALS Trending?

Years Total Debt/Equity % Change
Mar2025 0.25
92.31
Mar2024 0.13
-71.74
Mar2023 0.46
15.00
Mar2022 0.4
-40.30
Mar2021 0.67 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Total Debt/Equity ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹57,008.6 Cr 1.2% 4% 43.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,054.0 Cr 0.9% 6.2% -1.3% Stock Analytics
DIVIS LABORATORIES ₹167,075.0 Cr 2% 4.8% 4.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,904.0 Cr 3.6% 6% 36.9% Stock Analytics
CIPLA ₹107,358.0 Cr -0.1% -3% -8.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,813.0 Cr 1% 10.8% 4.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.2%

4%

43.9%

SENSEX

-1.4%

0.4%

8.3%


You may also like the below Video Courses